ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,320.76
0.43%
Dow Jones
42,374.32
0.47%
Gold vs US Dollar
2,645.07
-1.03%
Brent Oil
71.225
0.39%
Bitcoin
65,811.80
0.96%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ovid Therapeutics Inc (OVID)

  7. Ovid Therapeutics Inc (OVID) News

Ovid Therapeutics (OVID)

Ovid Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OVID
DateTimeSourceHeadlineSymbolCompany
26/09/202413:00GlobeNewswire Inc.Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating OV329 Does Not Accumulate in Animal Eyes in Contrast with VigabatrinNASDAQ:OVIDOvid Therapeutics Inc
11/09/202422:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
11/09/202422:36Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
11/09/202421:57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
11/09/202413:00GlobeNewswire Inc.Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future GrowthNASDAQ:OVIDOvid Therapeutics Inc
04/09/202413:00GlobeNewswire Inc.Ovid Therapeutics to Present at Upcoming September Investor ConferencesNASDAQ:OVIDOvid Therapeutics Inc
13/08/202413:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OVIDOvid Therapeutics Inc
13/08/202413:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
13/08/202413:00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
08/08/202413:00GlobeNewswire Inc.Ovid Therapeutics Appoints Dr. Amanda Banks, Experienced Biotech Leader & Physician as Chief Development OfficerNASDAQ:OVIDOvid Therapeutics Inc
02/08/202422:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
30/07/202413:00GlobeNewswire Inc.Ovid Therapeutics to Present at Upcoming August Investor ConferencesNASDAQ:OVIDOvid Therapeutics Inc
23/07/202413:00GlobeNewswire Inc.Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and EpileptologistsNASDAQ:OVIDOvid Therapeutics Inc
10/07/202413:00GlobeNewswire Inc.eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant SeizuresNASDAQ:OVIDOvid Therapeutics Inc
01/07/202413:00GlobeNewswire Inc.Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous MalformationsNASDAQ:OVIDOvid Therapeutics Inc
17/06/202412:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
17/06/202411:55GlobeNewswire Inc.Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for SoticlestatNASDAQ:OVIDOvid Therapeutics Inc
07/06/202421:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
14/05/202422:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OVIDOvid Therapeutics Inc
14/05/202413:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OVIDOvid Therapeutics Inc
14/05/202413:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
14/05/202413:00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
13/05/202412:00GlobeNewswire Inc.Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:OVIDOvid Therapeutics Inc
04/04/202413:00GlobeNewswire Inc.Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:OVIDOvid Therapeutics Inc
08/03/202413:24Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:OVIDOvid Therapeutics Inc
08/03/202413:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
08/03/202413:00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
28/02/202413:00GlobeNewswire Inc.Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:OVIDOvid Therapeutics Inc
26/02/202423:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
26/02/202423:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:OVID

Your Recent History

NASDAQ
COOP
Mr Cooper
NASDAQ
EMIF
iShares Emerging Markets...
AMEX
ISL
COIN
ZEROLUSD
ZeroLiquid
NYSE
EHT
Eaton Vance 2021 Target ...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved